A critical breakthrough in cancer study is emerging with the use of VHH fragments to re-engage damaged p53. This crucial malignant protector protein is frequently disabled in many types of cancer, causing uncontrolled https://hylistings.com/story23341041/nanobodies-reactivate-the-p53-protein-new-potential-pathway-for-tumor-treatment